Hält derzeit Positionen bei Adaptimmune Therapeutics PLC and WAVE Life Sciences Ltd
Position | Company | Period |
---|---|---|
Chief Financial Officer | Adaptimmune Therapeutics PLC | 1. März 2015 - |
Independent Director | WAVE Life Sciences Ltd | 1. Februar 2017 - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
30.080
-40.1%
0,6720.244 USD |
30.080 -40.1% | 0,67 | 20.244 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
17.257
-39.5%
0,8514.739 USD |
17.257 -39.5% | 0,85 | 14.739 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
11.945
-39.4%
0,849.994 USD |
11.945 -39.4% | 0,84 | 9.994 USD | |
2023-09-01 | 2023-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.403
-41.1%
0,781.874 USD |
2.403 -41.1% | 0,78 | 1.874 USD | |
2023-06-27 | 2023-06-27 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.333
-39.9%
0,922.146 USD |
2.333 -39.9% | 0,92 | 2.146 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
10.057
-43.0%
1,8618.686 USD |
10.057 -43.0% | 1,86 | 18.686 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.073
-43.3%
1,698.594 USD |
5.073 -43.3% | 1,69 | 8.594 USD | |
2022-09-01 | 2022-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.536
-43.3%
1,974.993 USD |
2.536 -43.3% | 1,97 | 4.993 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
11.096
-47.4%
3,1935.416 USD |
11.096 -47.4% | 3,19 | 35.416 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.046
-47.6%
3,5410.795 USD |
3.046 -47.6% | 3,54 | 10.795 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
14.362
-47.3%
3,5651.081 USD |
14.362 -47.3% | 3,56 | 51.081 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.532
-47.3%
4,0622.483 USD |
5.532 -47.3% | 4,06 | 22.483 USD | |
2021-06-28 | 2021-06-28 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.794
-47.7%
4,3712.210 USD |
2.794 -47.7% | 4,37 | 12.210 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
9.879
-42.2%
5,6756.009 USD |
9.879 -42.2% | 5,67 | 56.009 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.707
-42.3%
6,1516.654 USD |
2.707 -42.3% | 6,15 | 16.654 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.967
-42.4%
5,3326.464 USD |
4.967 -42.4% | 5,33 | 26.464 USD | |
2020-09-02 | 2020-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.776
-47.4%
8,5123.637 USD |
2.776 -47.4% | 8,51 | 23.637 USD | |
2020-08-04 | 2020-08-03 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.788
-47.6%
9,2525.789 USD |
2.788 -47.6% | 9,25 | 25.789 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.236
-50.5%
5,1316.616 USD |
3.236 -50.5% | 5,13 | 16.616 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.900
-50.4%
1,207.080 USD |
5.900 -50.4% | 1,20 | 7.080 USD | |
2019-01-16 | 2019-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.084
-48.2%
5,3716.559 USD |
3.084 -48.2% | 5,37 | 16.559 USD |